Vector-Borne Disease National Strategy

As mandated by the Kay Hagan Tick Act, signed into law in 2019 as part of the FY 2020 Further Consolidated Appropriations Act, OASH is working closely with CDC to develop a National Strategy to address Vector-Borne Diseases carried by ticks and other blood-feeding vectors. 

The National Strategy will identify:

  • gaps and unnecessary duplication in federally funded programs
  • strategic goals to address vector-borne diseases
  • benchmarks to measure progress toward achieving such goals

The National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans (CDC, 2020) lays a foundation for developing and executing a full National Strategy that details the activities needed to accomplish the articulated goals.

Content created by Assistant Secretary for Health (ASH)
Content last reviewed